Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | BRD4 | O60885 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL756988 | 0.89 | BRD4 (0.56) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL5621836 | 0.84 | ALDH1A1 (0.70) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL8004920 | 0.83 | ALOX5 (0.54) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL30035530 | 0.83 | ALOX5 (0.54) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL24307283 | 0.82 | ALOX5 (0.50) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL24306812 | 0.81 | ALOX5 (0.52) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL24306342 | 0.81 | ALOX5 (0.52) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL24306786 | 0.81 | ALOX5 (0.52) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL24306851 | 0.81 | ALOX5 (0.52) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD | |
| SCHEMBL24306807 | 0.81 | ALOX5 (0.52) | ALDH1A1KDM4ESMN1; SMN2POLBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4081521-B1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LTD (IN) | 2025-12-10 | — | — | EP | disclosed |
| US-12435066-B2 | Substituted tricyclic compounds | LUPIN LIMITED (IN) | 2025-10-07 | — | — | US | disclosed |
| CN-114746411-B | Substituted tricyclic compounds | 印度鲁宾有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-115605476-B | Substituted tricyclic compounds | 鲁宾有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-4065575-B1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LTD (IN) | 2024-01-31 | — | — | EP | disclosed |
| US-20230119316-A1 | Substituted Tricyclic Compounds | LUPIN LIMITED (IN) | 2023-04-20 | — | — | US | disclosed |
| US-20230013778-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LIMITED (IN) | 2023-01-19 | — | — | US | disclosed |
| US-20230013778-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LIMITED (IN) | 2023-01-19 | — | — | US | disclosed |
| CN-115605476-A | Substituted tricyclic compounds | 鲁宾有限公司（IN） | 2023-01-13 | — | — | CN | disclosed |
| EP-4081521-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | Lupin Limited (IN) | 2022-11-02 | — | — | EP | disclosed |
| EP-2119702-A1 | AMIDE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2009-11-18 | — | — | EP | disclosed |
| US-20090012055-A1 | Organic compounds | HEROLD PETER | 2009-01-08 | — | — | US | disclosed |
| EP-1961752-A2 | Piperidine Compounds | Speedel Experimenta AG (CH) | 2008-08-27 | — | — | EP | disclosed |
| EP-1670760-A1 | ORGANIC COMPOUNDS | Speedel Experimenta AG (CH) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005061457-A1 | ORGANIC COMPOUNDS | SPEEDEL EXPERIMENTA AG (CH) | 2005-07-07 | — | — | WO | disclosed |
| CN-1060769-C | 1,4-benzoxazine derivatives, pharmaceutical composition containing the same and use thereof | KENEBO LTD (JP) | 2001-01-17 | — | — | CN | disclosed |
| EP-0719766-B1 | 1,4-Benzoxazine derivative, pharmaceutical composition containing the same and use thereof | KANEBO LTD (JP) | 2000-04-12 | — | — | EP | disclosed |
| US-5597820-A | CARDIOVASCULAR DISORDERS | KANEBO, LTD. (JP) | 1997-01-28 | — | — | US | disclosed |
| CN-1130183-A | 1,4-benzoxazine derivatives, pharmaceutical composition containing the same and use thereof | KANEBO LTD (JP) | 1996-09-04 | — | — | CN | disclosed |
| EP-0719766-A1 | 1,4-Benzoxazine derivative, pharmaceutical composition containing the same and use thereof | KANEBO LTD. (JP) | 1996-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230013778-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | SOS1, RSU1, KSR1 | ALDH1A1 3879/4885KDM4E 4652/4885SMN1; SMN2 575/4885 |
| US-20090012055-A1 | Organic compounds | REN, ACE, ACE2 | ALDH1A1 142/4885KDM4E 1843/4885SMN1; SMN2 4291/4885 |
| US-20230119316-A1 | Substituted Tricyclic Compounds | SOS1, RSU1, KSR1 | ALDH1A1 3322/4885KDM4E 4661/4885SMN1; SMN2 619/4885 |
| US-12435066-B2 | Substituted tricyclic compounds | SOS1, RSU1, KSR1 | ALDH1A1 3879/4885KDM4E 4652/4885SMN1; SMN2 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.